Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Jun 13, 2024

BUY
$0.68 - $1.25 $13,785 - $25,341
20,273 New
20,273 $14,000
Q4 2022

Feb 01, 2023

BUY
$0.96 - $1.34 $17,804 - $24,851
18,546 Added 5.44%
359,279 $370,000
Q3 2022

Nov 10, 2022

BUY
$1.02 - $2.23 $15,548 - $33,994
15,244 Added 4.68%
340,733 $487,000
Q2 2022

Aug 11, 2022

SELL
$0.94 - $1.94 $4,363 - $9,005
-4,642 Reduced 1.41%
325,489 $353,000
Q1 2022

May 12, 2022

SELL
$1.54 - $3.71 $352,124 - $848,298
-228,652 Reduced 40.92%
330,131 $654,000
Q4 2021

Feb 11, 2022

BUY
$2.58 - $3.91 $1.44 Million - $2.18 Million
558,783 New
558,783 $1.54 Million

Others Institutions Holding SENS

About Senseonics Holdings, Inc.


  • Ticker SENS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 465,447,008
  • Market Cap $363M
  • Description
  • Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...
More about SENS
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.